We are live on ! Find out more
KRON

Kronos Bio
KRON

Delisted

KRON was delisted on the 20th of June, 2025.

Back to rankings

80 hedge funds and large institutions have $54.3M invested in Kronos Bio in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 26 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more capital invested

Capital invested by funds: $47.3M → $54.3M (+$6.99M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1.4% less ownership

Funds ownership: 56.21% → 54.82% (-1.4%)

8% less funds holding

Funds holding: 87 → 80 (-7)

30% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 23

42% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 26

Holders
80
Holders Change
-7
Holders Change %
-8.05%
% of All Funds
1.26%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
15
Reduced
26
Closed
23
Calls
$30K
Puts
–
Net Calls
+$30K
Net Calls Change
+$12K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$4.47M
2
PCIG
Partners Capital Investment Group
Massachusetts
+$1.81M
3
Mariner
Mariner
Kansas
+$1.45M
4
AI
Acuitas Investments
Washington
+$522K
5
ACP
Acuta Capital Partners
California
+$500K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$4.25M
2
BlackRock
BlackRock
New York
-$2.77M
3
State Street
State Street
Massachusetts
-$954K
4
Morgan Stanley
Morgan Stanley
New York
-$662K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$587K
Name Holding Trade Value Shares
Change 		Change in
Stake
PFMU
26
Privium Fund Management (UK)
United Kingdom
$485K – – –
CM
27
CM Management
Florida
$430K +$111K +70,000 +39%
Charles Schwab
28
Charles Schwab
California
$419K -$115K -72,215 -23%
Squarepoint
29
Squarepoint
New York
$388K +$285K +179,572 +390%
Citadel Advisors
30
Citadel Advisors
Florida
$369K +$204K +128,508 +149%
State Street
31
State Street
Massachusetts
$307K -$954K -601,102 -77%
WP
32
Woodline Partners
California
$299K – – –
SM
33
Scoggin Management
New York
$267K +$246K +155,232 New
Marshall Wace
34
Marshall Wace
United Kingdom
$217K -$98.3K -61,892 -33%
CC
35
Casdin Capital
New York
$213K – – –
KCM
36
Kennedy Capital Management
Missouri
$183K +$144K +90,472 +565%
Morgan Stanley
37
Morgan Stanley
New York
$164K -$662K -417,011 -81%
Northern Trust
38
Northern Trust
Illinois
$161K -$408K -257,046 -73%
SB
39
Samsara BioCapital
California
$134K – – –
BCM
40
Bridgeway Capital Management
Texas
$134K -$112K -70,610 -48%
MAM
41
Marquette Asset Management
Minnesota
$117K +$30.9K +19,484 +40%
JP Morgan Chase
42
JP Morgan Chase
New York
$117K -$4.25M -2,674,233 -98%
State of Wisconsin Investment Board
43
State of Wisconsin Investment Board
Wisconsin
$110K -$62.1K -39,100 -38%
Qube Research & Technologies (QRT)
44
Qube Research & Technologies (QRT)
United Kingdom
$102K +$94.4K +59,433 New
YIH
45
Y-Intercept (HK)
Hong Kong
$99.7K +$92K +57,952 New
Jacobs Levy Equity Management
46
Jacobs Levy Equity Management
New Jersey
$95.1K +$87.7K +55,265 New
CBA
47
Coastal Bridge Advisors
Connecticut
$89.4K – – –
CIC
48
Cornercap Investment Counsel
Georgia
$70.2K +$10.3K +6,481 +19%
FA
49
Forefront Analytics
Pennsylvania
$67.2K -$360 -227 -0.6%
HSBC Holdings
50
HSBC Holdings
United Kingdom
$65.8K – – –
1
2
3 4 5

KRON Hedge Fund Activity: Q2 2023 in Review

80 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q2 2023, worth a combined $54.3M — up 15% from $47.3M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of KRON and 16 opened new positions — a net loss of 7 holders — while 26 trimmed existing stakes and 15 added.

The largest buyer was BVF Inc, opening a new position worth an estimated $4.47M. The largest seller was JP Morgan Chase, cutting an estimated $4.25M.

  • 80 institutional investors held Kronos Bio (KRON) as of Q2 2023, down from 87 in Q1 2023.
  • Funds reported $54.3M of Kronos Bio stock for Q2 2023, up 15% quarter-over-quarter.
  • 16 funds opened new Kronos Bio positions in Q2 2023 and 23 closed out, a net change of -7 holders.
  • The largest Kronos Bio buyer in Q2 2023 was BVF Inc, an estimated $4.47M added.
  • The largest Kronos Bio seller in Q2 2023 was JP Morgan Chase, an estimated $4.25M sold.

Based on aggregated 13F filings for Q2 2023.